3
Shared Docs
3
Same-Page
3 / 3
Mentions
of the =obert Wood Johnson Foundation to pursue initiatives to integrate =lacebo studies into the education framework of Harvard University. Also, the Food and Drug Administration (FDA) has asked to collaborate =ith us to develop new research designs that would more efficiently =ontrol for placebo effects in randomized trials.
wishes, Ted Ted J. Kaptchuk Associate Professor of Medicine Harvard Medical School Director, Program in Placebo Studies & Therapeutic Encounter Beth Israel Deaconess Medical Center Boston, MA 02215 Phone: Email: Web: www.programinplacebostudies.org <?xml version=.0" encoding=TF•8"?> <!DOCTYPE plist PUBLIC "-//Apple//DTD PLIST 1.0/
of the =obert Wood Johnson Foundation to pursue initiatives to integrate =lacebo studies into the education framework of Harvard University. Also, the Food and Drug Administration (FDA) has asked to collaborate =ith us to develop new research designs that would more efficiently =ontrol for placebo effects in randomized trials.
wishes, Ted Ted J. Kaptchuk Associate Professor of Medicine Harvard Medical School Director, Program in Placebo Studies & Therapeutic Encounter Beth Israel Deaconess Medical Center Boston, MA 02215 Phone Email: Web: www.programinplacebostudies.org <?xml version=.0" encoding=TF•8"?> <!DOCTYPE plist PUBLIC "-//Apple//DTD PLIST 1.0//
of the =obert Wood Johnson Foundation to pursue initiatives to integrate =lacebo studies into the education framework of Harvard University. Also, the Food and Drug Administration (FDA) has asked to collaborate =ith us to develop new research designs that would more efficiently =ontrol for placebo effects in randomized trials.
wishes, Ted Ted J. Kaptchuk Associate Professor of Medicine Harvard Medical School Director, Program in Placebo Studies & Therapeutic Encounter Beth Israel Deaconess Medical Center Boston, MA 02215 Phone: Email: Web: www.programinplacebostudies.org <?xml version=.0" encoding=TF•8"?> <!DOCTYPE plist PUBLIC "-//Apple//DTD PLIST 1.0/
Entities connected to both the Food and Drug Administration and Beth Israel Deaconess Medical Center Boston